Publications database

Drug strategies and plans adopted over the last five years by six intergovernmental organisations engage 148 countries in five continents. Here, we present a brief overview of these documents, looking at their...

This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator...

This publication is an update of Prevention of substance abuse, published in 2007. Like the previous analysis, it is a translation of a German study that presents a state-of-the-art review of prevention...

This Topic overview aims to summarise the information and simplify comparison between quantity limits for possession and supply offences involving the four most common drugs. Separate tables are given: quantities established for...

Assessing the validity of the information that has been collected is a relevant issue in any study. After the publication of the 2011 ESPAD report and in the view of preparations for...

In this issue: New technical report on estimating trends in injecting drug use | EMCDDA: 20 years of monitoring | Memorandum of Understanding with Armenia | EMCDDA launches IPA 5 project with...

Based on the options provided by the international drug control legal framework, this paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

This report presents the key activities performed by the EMCDDA and Europol in 2014, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the...

This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new...